Head-To-Head Survey: Cyanotech (CYAN) vs. Its Competitors

Insider & Institutional Ownership

24.4% of Cyanotech shares are held by institutional investors. Comparatively, 32.8% of shares of all “Pharmaceuticals” companies are held by institutional investors. 34.4% of Cyanotech shares are held by insiders. Comparatively, 14.1% of shares of all “Pharmaceuticals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Cyanotech and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Cyanotech $22.49 million -$1.28 million -1.80
Cyanotech Competitors $3.48 billion $3.12 billion 541.46

Cyanotech’s peers have higher revenue and earnings than Cyanotech. Cyanotech is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Cyanotech and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cyanotech -4.82% -16.24% -5.56%
Cyanotech Competitors -2,303.79% -221.76% -17.81%

Risk & Volatility

Cyanotech has a beta of 0.1, suggesting that its stock price is 90% less volatile than the S&P 500. Comparatively, Cyanotech’s peers have a beta of -3.12, suggesting that their average stock price is 412% less volatile than the S&P 500.

Summary

Cyanotech beats its peers on 5 of the 9 factors compared.

About Cyanotech

(Get Free Report)

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.